# 510(k) Summary

# Submitter information Contact person:

Philip Liu Manager, Regulatory Affairs & Compliance

# Address:

Siemens Medical Solutions Diagnostics   
511 Benedict Avenue   
Tarrytown, NY 10591

# Phone:

914-524-2443   
914-524-2500 (fax)

Date summary prepared:

Device Trade or Proprietary Name: ADVIA® Chemistry Enzymatic Creatinine2 (ECRE_2)

Device Common/Usual Name or Classification Name:

Enzymatic Method, Creatinine Test System

Classification Number/Class: JFY / Class II

This 510(k) summary of safety and effectiveness is being submitted in accordance with the requirements of 21 CFR 807.92:

The assigned 510(k) number is:

Predicate Devices:   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Predicate Device #1</td><td rowspan=1 colspan=1>Predicate Device #2</td></tr><tr><td rowspan=1 colspan=1>Device Name</td><td rowspan=1 colspan=1>ADVIA® Chemistry SystemsCreatinine_2</td><td rowspan=1 colspan=1>ADVIA® Chemistry SystemsEnzymatic Creatinine</td></tr><tr><td rowspan=1 colspan=1>Common name</td><td rowspan=1 colspan=1>Creatinine Test System</td><td rowspan=1 colspan=1>Creatinine Test System</td></tr><tr><td rowspan=1 colspan=1>510(k) Number</td><td rowspan=1 colspan=1>k973993</td><td rowspan=1 colspan=1>k991576</td></tr><tr><td rowspan=1 colspan=1>Manufacturer</td><td rowspan=1 colspan=1>Siemens Medical SolutionsDiagnostics (formerly BayerHealthCare LLC)</td><td rowspan=1 colspan=1>Siemens Medical SolutionsDiagnostics (formerly BayerHealthCare LLC)</td></tr></table>

# Device Description:

The ADVIA Chemistry Enzymatic Creatinine_2 is used for the in vitro quantitative determination of creatinine in human serum, plasma and urine on the ADVIA®

Siemens Medical Solutions Diagnostics   
ADVIA Chemistry Enzymatic Creatinine_2 Premarket Notification 510(k)   
Section 5 - 510(k) Summary

Chemistry Systems. The proposed labeling indicates the ADVIA Chemistry Enzymatic Creatinine_2 reagents can be used on the ADVIA Chemistry 1200 / 1650 / 1800 / 2400 Systems.

The principle of the method is based on the enzymatic method employing creatininase, creatinase, sarcosine oxidase, horseradish peroxidase and N-(3-sulfopropyl)-3- methoxy-5-methylaniline (HMMPS) as the color agent. When a sample is mixed with Reagent 1 and Reagent 2, creatinine in the sample is converted to creatine by the action of creatininase. The creatine formed is hydrolyzed by creatinase to produce sarcosine and urea. The sarcosine is then decomposed by sarcosine oxidase to form glycine, formaldehyde and hydrogen peroxide. In the presence of peroxidase (POD), the hydrogen peroxide formed yields a blue pigment by quantitative oxidative condensation with N-(3-sulfopropyl)-3-methoxy-5-methylaniline (HMMPS) and 4- aminoantipyrine. The creatinine concentration is obtained by measuring the absorbance of blue color. The increase in optical absorbance is determined as an endpoint assay, which is proportional to the concentration of creatinine in the sample.

# Statement of Intended Use:

The ADVIA Chemistry Enzymatic Creatinine_2 assay is for in vitro diagnostic use in the quantitative determination of creatinine in human serum, plasma or urine on the ADVIA® Chemistry Systems. Such measurements are used in the diagnosis and treatment of renal disease, and in monitoring renal dialysis.

# Comparison to the Predicate Device:

# Similarities

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>ADVIA ChemistryEnzymatic Creatinine_2(ECRE_2)(new device)</td><td rowspan=1 colspan=1>ADVIA Chemistry Creatinine_2(CREÁ_2)(predicate device)</td><td rowspan=1 colspan=1>ADVIA Chemistry EnzymaticCreatinine(CREA_E)(predicate device)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>Quantitative determination ofcreatinine</td><td rowspan=1 colspan=1>Quantitative determination ofcreatinine</td><td rowspan=1 colspan=1>Quantitative determination ofcreatinine</td></tr><tr><td rowspan=1 colspan=1>Specimen Type</td><td rowspan=1 colspan=1>Human serum or plasma(lithium heparin / K2EDTA) orurine</td><td rowspan=1 colspan=1>Human serum or plasma(lithium heparin) or urine</td><td rowspan=1 colspan=1>Human serum or plasma(lithium heparin)</td></tr><tr><td rowspan=1 colspan=1>Calibration</td><td rowspan=1 colspan=1>Single point</td><td rowspan=1 colspan=1>Single point</td><td rowspan=1 colspan=1>Single point</td></tr><tr><td rowspan=1 colspan=1>Expected ValuesSerum/plasma</td><td rowspan=1 colspan=1>*Males:  0.6 - 1.1 mg/dL*Females: 0.5 - 0.8 mg/dL</td><td rowspan=1 colspan=1>Males:  0.7 - 1.3 mg/dLFemales: 0.5 - 1.1 mg/dL</td><td rowspan=1 colspan=1>**Males: 0.9 - 1.3 mg/dL**Females: 0.6 - 1.1 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Expected ValuesUrine</td><td rowspan=1 colspan=1>*Males:  800 - 2000 mg/day*Females: 600 - 1800 mg/day</td><td rowspan=1 colspan=1>*Males:  800 - 2000 mg/day*Females: 600 - 1800 mg/day</td><td rowspan=1 colspan=1>Not Applicable</td></tr></table>

\*Tietz NW. Clinical Guide to Laboratory Tests, $4 ^ { m }$ Edition \*\*Tietz NW. Clinical Guide to Laboratory Tests, ${ \mathfrak { F } } ^ { d }$ Edition

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>ADVIA Chemistry EnzymaticCreatinine_2 (ECRE_2)(new device)</td><td rowspan=1 colspan=1>ADVIA ChemistryCreatinine_2(CREA_2)(predicate device)</td><td rowspan=1 colspan=1>ADVIA Chemistry EnzymaticCreatinine(CREA_E)(predicate device)</td></tr><tr><td rowspan=1 colspan=1>Principle</td><td rowspan=1 colspan=1>Enzymatic (Creatininase)</td><td rowspan=1 colspan=1>Jaffe, alkaline picrate, kineticwith blank rate correction</td><td rowspan=1 colspan=1>Enzymatic (CreatinineDeiminase / GLDH)</td></tr><tr><td rowspan=1 colspan=1>Reaction Type</td><td rowspan=1 colspan=1>Colorimetric Endpoint</td><td rowspan=1 colspan=1>Colorimetric Rate</td><td rowspan=1 colspan=1>Colorimetric Rate</td></tr><tr><td rowspan=1 colspan=1>Reagents</td><td rowspan=1 colspan=1>Two liquid reagents, ready touse</td><td rowspan=1 colspan=1>Two liquid reagents, ready touse</td><td rowspan=1 colspan=1>Two lyophilized reagents,requiring reconstitution</td></tr><tr><td rowspan=1 colspan=1>Standardization</td><td rowspan=1 colspan=1>ID-MS (SRM 967)</td><td rowspan=1 colspan=1>HPLC candidate referencemethod</td><td rowspan=1 colspan=1>HPLC candidate referencemethod</td></tr></table>

# Performance:

Substantial equivalence was demonstrated by testing several performance characteristics including imprecision, method comparison, interfering substances, serum/plasma equivalency, and analytical range. The following tables summarize the precision (total), interfering substances, analytical range, and method comparison results.

All of the evaluation studies gave acceptable results compared to the predicate devices. These studies support that the ADVIA Chemistry Enzymatic Creatinine_2 assay is substantially equivalent to the ADVIA Chemistry Creatinine_2 assay and the ADVIA Chemistry Enzymatic Creatinine assay that are currently marketed.

# Imprecision (Serum)

Imprecision (Urine)   

<table><tr><td rowspan=1 colspan=6>ADVIA Chemistry Enzymatic Creatinine_2</td><td rowspan=1 colspan=2>ADVIA ChemistryCreatinine_2</td><td rowspan=1 colspan=2>ADVIA ChemistryEnzymaticCreatinine</td></tr><tr><td rowspan=1 colspan=2>ADVIA 1650</td><td rowspan=1 colspan=2>ADVIA 2400</td><td rowspan=1 colspan=2>ADVIA 1200</td><td rowspan=1 colspan=2>ADVIA 1650</td><td rowspan=1 colspan=2>ADVIA 1650</td></tr><tr><td rowspan=1 colspan=1>Level(mg/dL)</td><td rowspan=1 colspan=1>Total CV(%)</td><td rowspan=1 colspan=1>Level(mg/dL)</td><td rowspan=1 colspan=1>Total CV(%)</td><td rowspan=1 colspan=1>Level(mg/dL)</td><td rowspan=1 colspan=1>Total CV(%)</td><td rowspan=1 colspan=1>Level(mg/dL)</td><td rowspan=1 colspan=1>Total CV(%)</td><td rowspan=1 colspan=1>Level(mg/dL)</td><td rowspan=1 colspan=1>Total CV(%)</td></tr><tr><td rowspan=1 colspan=1>1.29</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>1.28</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>1.29</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>--</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>--</td><td rowspan=1 colspan=1>--</td></tr><tr><td rowspan=1 colspan=1>1.76</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>1.75</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>1.73</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>5.7</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>6.4</td></tr><tr><td rowspan=1 colspan=1>3.07</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>3.06</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>3.04</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>--</td><td rowspan=1 colspan=1>--</td><td rowspan=1 colspan=1>6.1</td><td rowspan=1 colspan=1>2.3</td></tr><tr><td rowspan=1 colspan=1>8.80</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>8.81</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>8.79</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>8.4</td><td rowspan=1 colspan=1>3.4</td><td rowspan=1 colspan=1>9.5</td><td rowspan=1 colspan=1>2.0</td></tr></table>

<table><tr><td rowspan=1 colspan=6>ADVIA Chemistry Enzymatic Creatinine 2</td><td rowspan=1 colspan=6>ADVIA Chemistry Creatinine 2</td></tr><tr><td rowspan=1 colspan=2>ADVIA 1650</td><td rowspan=1 colspan=2>ADVIA 2400</td><td rowspan=1 colspan=2>ADVIA 1200</td><td rowspan=1 colspan=2>ADVIA 1650</td><td rowspan=1 colspan=2>ADVIA 1200</td><td rowspan=1 colspan=2>ADVIA 2400</td></tr><tr><td rowspan=1 colspan=1>Level(mg/dL)</td><td rowspan=1 colspan=1>Total CV(%)</td><td rowspan=1 colspan=1>Level(mg/dL)</td><td rowspan=1 colspan=1>Total CV(%)</td><td rowspan=1 colspan=1>Level(mg/dL)</td><td rowspan=1 colspan=1>Total CV(%)</td><td rowspan=1 colspan=1>Level(mg/dL)</td><td rowspan=1 colspan=1>Total CV(%)</td><td rowspan=1 colspan=1>Level(mg/dL)</td><td rowspan=1 colspan=1>Total CV(%)</td><td rowspan=1 colspan=1>Level(mg/dL)</td><td rowspan=1 colspan=1>Total CV(%)</td></tr><tr><td rowspan=1 colspan=1>41.56</td><td rowspan=1 colspan=1>1.3</td><td rowspan=1 colspan=1>41.13</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>42.34</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>--</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>77.27</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>77.54</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>79.78</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>81.5</td><td rowspan=1 colspan=1>4.3</td><td rowspan=1 colspan=1>79.7</td><td rowspan=1 colspan=1>2.1</td><td rowspan=1 colspan=1>80.7</td><td rowspan=1 colspan=1>2.1</td></tr><tr><td rowspan=1 colspan=1>130.59</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>131.33</td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1>133.09</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>202.7</td><td rowspan=1 colspan=1>1.8</td><td rowspan=1 colspan=1>182.5</td><td rowspan=1 colspan=1>1.9</td><td rowspan=1 colspan=1>199.7</td><td rowspan=1 colspan=1>1.4</td></tr></table>

Siemens Medical Solutions Diagnostics ADVIA Chemistry Enzymatic Creatinine_2 Premarket Notification 510(k) Section 5 - 510(k) Summary

Correlation (y $=$ ADVIA Chemistry Enzymatic Creatinine_2, $\mathbf { x } =$ comparison system)   

<table><tr><td rowspan=1 colspan=1>Specimen type,System (y)</td><td rowspan=1 colspan=1>Comparison System (x)</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>RegressionEquation</td><td rowspan=1 colspan=1>Sy.x(mg/dL)</td><td rowspan=1 colspan=1>r</td><td rowspan=1 colspan=1>SampleRange(mg/dL)</td></tr><tr><td rowspan=1 colspan=1>Serum, ADVIA1200</td><td rowspan=1 colspan=1>ADVIA 1200Creatinine 2</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>Y = 1.017x + 0.03</td><td rowspan=1 colspan=1>0.07</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>0.3-12.3</td></tr><tr><td rowspan=1 colspan=1>Serum, ADVIA1200</td><td rowspan=1 colspan=1>ADVIA 1200Enzymatic Creatinine</td><td rowspan=1 colspan=1>28</td><td rowspan=1 colspan=1>Y = 0.933x + 0.11</td><td rowspan=1 colspan=1>0.14</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>0.5 - 25.6</td></tr><tr><td rowspan=1 colspan=1>Serum, ADVIA1650</td><td rowspan=1 colspan=1>ADVIA 1650Creatinine 2</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>Y = 1.018x - 0.04</td><td rowspan=1 colspan=1>0.13</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>0.3-11.9</td></tr><tr><td rowspan=1 colspan=1>Serum, ADVIA1650</td><td rowspan=1 colspan=1>ADVIA 1650Enzymatic Creatinine</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>Y = 0.957x + 0.04</td><td rowspan=1 colspan=1>0.12</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>0.6 - 25.7</td></tr><tr><td rowspan=1 colspan=1>Serum, ADVIA2400</td><td rowspan=1 colspan=1>ADVIA 2400Creatinine 2</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>Y = 1.026x - 0.03</td><td rowspan=1 colspan=1>0.13</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>0.3-12.1</td></tr><tr><td rowspan=1 colspan=1>Serum, ADVIA2400</td><td rowspan=1 colspan=1>ADVIA 2400Enzymatic Creatinine</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>Y = 0.954x + 0.01</td><td rowspan=1 colspan=1>0.07</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>0.6 - 25.4</td></tr><tr><td rowspan=1 colspan=1>Urine, ADVIA1200</td><td rowspan=1 colspan=1>ADVIA 1200Creatinine 2</td><td rowspan=1 colspan=1>46</td><td rowspan=1 colspan=1>Y = 1.042x + 0.41</td><td rowspan=1 colspan=1>1.80</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>20.0 - 238.1</td></tr><tr><td rowspan=1 colspan=1>Urine, ADVIA1650</td><td rowspan=1 colspan=1>ADVIA 1650Creatinine2</td><td rowspan=1 colspan=1>49</td><td rowspan=1 colspan=1>Y =1.019x -0.99</td><td rowspan=1 colspan=1>1.88</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>17.8 - 239.4</td></tr><tr><td rowspan=1 colspan=1>Urine, ADVIA2400</td><td rowspan=1 colspan=1>ADVIA 2400Creatinine 2</td><td rowspan=1 colspan=1>44</td><td rowspan=1 colspan=1>Y = 1.025x + 2.47</td><td rowspan=1 colspan=1>2.99</td><td rowspan=1 colspan=1>0.999</td><td rowspan=1 colspan=1>18.9 - 218.1</td></tr></table>

# Interfering Substances (Enzymatic Creatinine 2)

<table><tr><td rowspan=2 colspan=1>InterferingSubstance</td><td rowspan=2 colspan=1>Conc.(mg/dL)</td><td rowspan=1 colspan=3>Creatinine conc.(mg/dL)</td><td rowspan=1 colspan=3>Effect(% change)</td></tr><tr><td rowspan=1 colspan=1>ADVIA1200</td><td rowspan=1 colspan=1>ADVIA1650</td><td rowspan=1 colspan=1>ADVIA2400</td><td rowspan=1 colspan=1>ADVIA1200</td><td rowspan=1 colspan=1>ADVIA1650</td><td rowspan=1 colspan=1>ADVIA2400</td></tr><tr><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>5001000</td><td rowspan=1 colspan=1>0.943.08</td><td rowspan=1 colspan=1>0.923.06</td><td rowspan=1 colspan=1>0.913.00</td><td rowspan=1 colspan=1>7.5-2.8</td><td rowspan=1 colspan=1>6.6-3.8</td><td rowspan=1 colspan=1>6.6- 2.2</td></tr><tr><td rowspan=1 colspan=1>Lipids (Intralipid)</td><td rowspan=1 colspan=1>10001000</td><td rowspan=1 colspan=1>0.913.09</td><td rowspan=1 colspan=1>0.883.03</td><td rowspan=1 colspan=1>0.872.97</td><td rowspan=1 colspan=1>6.6-2.4</td><td rowspan=1 colspan=1>-5.7-5.3</td><td rowspan=1 colspan=1>-1.2-4.2</td></tr><tr><td rowspan=1 colspan=1>Bilirubin, free</td><td rowspan=1 colspan=1>30.022.5</td><td rowspan=1 colspan=1>0.963.05</td><td rowspan=1 colspan=1>1.013.05</td><td rowspan=1 colspan=1>0.943.22</td><td rowspan=1 colspan=1>-8.9-6.6</td><td rowspan=1 colspan=1>-7.4-6.1</td><td rowspan=1 colspan=1>-9.6-9.8</td></tr><tr><td rowspan=1 colspan=1>Bilirubin, conjugated</td><td rowspan=1 colspan=1>30.030.0</td><td rowspan=1 colspan=1>0.922.96</td><td rowspan=1 colspan=1>0.902.97</td><td rowspan=1 colspan=1>0.912.94</td><td rowspan=1 colspan=1>-2.7-4.6</td><td rowspan=1 colspan=1>-5.6-5.4</td><td rowspan=1 colspan=1>-5.5-6.0</td></tr></table>

# Analytical Range - Serum/Plasma

<table><tr><td rowspan=1 colspan=1>Platform</td><td rowspan=1 colspan=1>ADVIA Chemistry EnzymaticCreatinine 2</td></tr><tr><td rowspan=1 colspan=1>ADVIA 1650</td><td rowspan=1 colspan=1>0.1 - 30.0 mg/dL</td></tr><tr><td rowspan=1 colspan=1>ADVIA 2400</td><td rowspan=1 colspan=1>0.1 - 30.0 mg/dL</td></tr><tr><td rowspan=1 colspan=1>ADVIA 1200</td><td rowspan=1 colspan=1>0.1 - 30.0 mg/dL</td></tr></table>

# Analytical Range - Urine

<table><tr><td rowspan=1 colspan=1>Platform</td><td rowspan=1 colspan=1>ADVIA Chemistry EnzymaticCreatinine2</td></tr><tr><td rowspan=1 colspan=1>ADVIA 1650</td><td rowspan=1 colspan=1>1.0 - 245 mg/dL</td></tr><tr><td rowspan=1 colspan=1>ADVIA 2400</td><td rowspan=1 colspan=1>1.0 - 245 mg/dL</td></tr><tr><td rowspan=1 colspan=1>ADVIA 1200</td><td rowspan=1 colspan=1>1.0 - 245 mg/dL</td></tr></table>

# Conclusions:

The ADVIA Chemistry Enzymatic Creatinine_2 assay is substantially equivalent to other products in commercial distribution intended for similar use. Most notably, it is substantially equivalent to the currently marketed Siemens Diagnostics (formerly Bayer HealthCare LLC) ADVIA Chemistry Creatinine_2 (k973993) and Enzymatic Creatinine methods (k991576).

# AUG - 3 2007

Siemens Medical Solutions Diagnostics   
c/o Mr. Philip Liu, Manager, Regulatory Affairs & Compliance   
511 Benedict Avenue   
Tarrytown, NY 10591

Re: k070727 Trade Name: Advia Chemistry Enzymatic Creatinine-2 Regulation Number: 21 CFR 862.1225 Regulation Name: Creatinine test system Regulatory Class: Class II Product Code: JFY Dated: July 20, 2007 Received: July 23, 2007

Dear Mr. Liu:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0490. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address at   
http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Jean M.Coopes, M.S., D.V.M. Jean M. Cooper, M.S., D.V.M.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and   
Radiological Health

# Indications for Use

510(k) Number (if known):

![](images/7a8b1f0bed5eb56268f6f2ed99b70d8a8215f2b902727a72bb42decfd7a3ce3a.jpg)

Device Name: ADVIA CHEMISTRY ENZYMATIC CREATININE 2

Indications For Use:

For in vitro diagnostic use in the quantitative determination of creatinine in human serum, plasma, and urine on the ADVIA Chemistry Systems. Such measurements are used in the diagnosis and treatment of renal diseases, and in monitoring renal dialysis.

Concurrence f CDRH, Office of In Vito Diagnostic Devices (OIVD)

Cauof C Benan

Office of In Vitro Diagnostic Device Evaluation and Safety

Page 1 of 1_

K070727